25 Results for "

immune-modulating

" in MedChemExpress (MCE) Product Catalog:
Products (25)

25 Results for "immune-modulating" in MCE Product Catalog:

1304
1304 Publications Verification
Cat. No.: HY-17589A
CAS No.: 54-05-7
Chloroquine is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis. Chloroquine is an autophagy and toll-like receptors (TLRs) inhibitor. Chloroquine is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro (EC50=1.13 μM) .
loading...
    loading...
1304
1304 Publications Verification
Cat. No.: HY-17589
CAS No.: 50-63-5
Chloroquine phosphate is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis. Chloroquine phosphate is an autophagy and toll-like receptors (TLRs) inhibitor. Chloroquine phosphate is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro (EC50=1.13 μM) .
loading...
    loading...
1304
1304 Publications Verification
Cat. No.: HY-17589B
CAS No.: 3545-67-3
Chloroquine dihydrochloride is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis. Chloroquine dihydrochloride is an autophagy and toll-like receptors (TLRs) inhibitor. Chloroquine dihydrochloride is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro (EC50=1.13 μM) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B0300
CAS No.: 52-67-5
Synonyms: D-(-)-Penicillamine
Penicillamine (D-(-)-Penicillamine) is a penicillin metabolic degradation product, can be used as a heavy metal chelator. Penicillamine increases free copper and increases oxidative stress. Penicillamine has effect of seizures through nitric oxide/NMDA pathways. Penicillamine is a potential immune modulator. Penicillamine can be used for the research of Wilson disease, rheumatoid arthritis, and cystinuria .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-17589AR
CAS No.: 54-05-7
Chloroquine (Standard) is the analytical standard of Chloroquine. This product is intended for research and analytical applications. Chloroquine is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis. Chloroquine is an autophagy and toll-like receptors (TLRs) inhibitor. Chloroquine is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro (EC50=1.13 μM) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-150724
CAS No.: 937402-51-2
Synonyms: 1018 ISS
Research Areas:  

Inflammation/Immunology

ODN 1018 (1018 ISS) is a TLR9 agonist and immune modulator. ODN 1018 exhibits adjuvant activity and augments CD8+ T cell responses with LNP-encapsulated OVA peptides. ODN 1018 triggers sustained suppression of allergic airway inflammation. ODN 1018 can be used for the research of allergic asthma and systemic lupus erythematosus .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P99279
CAS No.: 648904-28-3
Synonyms: Anti-Human Phosphatidylserine Recombinant Antibody; PGN-401; CH3G4

Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

Bavituximab (Anti-Human Phosphatidylserine Recombinant Antibody) is a phosphatidylserine (PS)-targeting monoclonal antibody, suppresses tumor growth by targeting tumor vasculature and reactivating antitumor immunity. Bavituximab plus Paclitaxel (HY-B0015) and Carboplatin (HY-17393), have enhanced inhibition on non-small-cell lung cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-150724C
Purity:  97.44%
Synonyms: 1018 ISS sodium
Research Areas:  

Inflammation/Immunology

ODN 1018 (1018 ISS) sodium is a TLR9 agonist and immune modulator. ODN 1018 sodium exhibits adjuvant activity and augments CD8+ T cell responses with LNP-encapsulated OVA peptides. ODN 1018 sodium triggers sustained suppression of allergic airway inflammation. ODN 1018 sodium can be used for the research of allergic asthma and systemic lupus erythematosus .
loading...
    loading...
Cat. No.: HY-152830
CAS No.: 2394874-66-7
Purity:  99.51%
Synonyms: Q702
Target:  

c-Fms TAM Receptor MHC

Research Areas:  

Cancer

Adrixetinib (Q702) is an orally active triple inhibitor against CSF1R, Mer, and Axl, with Kd values of 8.7 nM, 0.8 nM, and 0.3 nM, respectively. Adrixetinib acts as a potent immune modulator that remodels the tumor microenvironment. Adrixetinib increases the abundance of M1 macrophages and CD8⁺ T cells, while decreasing the levels of M2 macrophages and myeloid-derived suppressor cells (MDSCs). Adrixetinib upregulates the expression of MHC class I and E-cadherin in tumor cells. Adrixetinib shows remarkable antitumor efficacy in syngeneic mouse tumor models. Adrixetinib is suitable for the research of breast cancer, renal adenocarcinoma, colon carcinoma, and melanoma .
loading...
    loading...
Cat. No.: HY-113008A
CAS No.: 7699-35-6
Purity:  99.92%
Synonyms: (Z)-Urocanic acid; cis-UCA
Target:  

5-HT Receptor

Research Areas:  

Inflammation/Immunology

cis-Urocanic acid is a 5-HT2A receptor agonist. cis-Urocanic acid binds to 5-HT receptor with relatively high affinity (Kd=4.6 nM). cis-Urocanic acid is an immune modulator that induces immunosuppression by binding to the 5-HT2A receptor .
loading...
    loading...
Cat. No.: HY-101058A
Purity:  95.11%
Target:  

PD-1/PD-L1

Research Areas:  

Inflammation/Immunology Cancer

PD1-PDL1-IN 1 TFA (compound 16) is a potent programmed cell death 1 (PD-1) inhibitor. PD1-PDL1-IN 1 TFA is useful as immune modulator .
loading...
    loading...
Cat. No.: HY-144501
CAS No.: 2230218-36-5
Purity:  98.14%
D18 is an immune modulator. D18 acts as a TLR7/8 dual agonist (EC50 = 24 nM for hTLR7 and 10 nM for hTLR8, respectively). D18 increases PD-L1 expression through epigenetic regulation, thus sensitizing tumors to PD-1/PD-L1 blockade. D18 is a ADC cytotoxin uesd for the systhesis of ADC HE-S2 (HY-144497). D18 has strong immune activation and anti-tumor activity. D18 commonly used in cancer research, such as colon cancer .
loading...
    loading...
Cat. No.: HY-N11451
CAS No.: 25541-09-7
Synonyms: LNFP-III
Lacto-N-fucopentaose III (LNFP-III) is an immune modulator. Lacto-N-fucopentaose III reduces the severity of experimental autoimmune encephalomyelitis (EAE) and CNS inflammation .
loading...
    loading...
Cat. No.: HY-106647
CAS No.: 1446418-48-9
Purity:  99.61%
Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Abacavir hydroxyacetate is an orally active inhibitor of IL-20 and PRINS. Abacavir hydroxyacetate reduces proliferation rate of skin in psoriasis as an immune modulator. Abacavir hydroxyacetate can be used for the research of inflammatory skin problems .
loading...
    loading...
Cat. No.: HY-N12737
CAS No.: 216987-13-2
15-epi-Danshenol A is a diterpenoid with an immune-modulating activity. 15-epi-Danshenol A shows inhibitory effect on B lymphoblasts cells in a concentration-dependent manner .
loading...
    loading...
Cat. No.: HY-101058
CAS No.: 2005454-12-4
Target:  

PD-1/PD-L1

Research Areas:  

Inflammation/Immunology

PD1-PDL1-IN 1 (compound 16) is a potent programmed cell death 1 (PD-1) inhibitor. PD1-PDL1-IN 1 is useful as immune modulator .
loading...
    loading...
Cat. No.: HY-152830A
Purity:  99.82%
Synonyms: Q702 TFA
Target:  

c-Fms TAM Receptor MHC

Research Areas:  

Cancer

Adrixetinib (Q702) TFA is an orally active triple inhibitor against CSF1R, Mer, and Axl, with Kd values of 8.7 nM, 0.8 nM, and 0.3 nM, respectively. Adrixetinib TFA acts as a potent immune modulator that remodels the tumor microenvironment. Adrixetinib TFA increases the abundance of M1 macrophages and CD8⁺ T cells, while decreasing the levels of M2 macrophages and myeloid-derived suppressor cells (MDSCs). Adrixetinib TFA upregulates the expression of MHC class I and E-cadherin in tumor cells. Adrixetinib TFA shows remarkable antitumor efficacy in syngeneic mouse tumor models. Adrixetinib TFA is suitable for the research of breast cancer, renal adenocarcinoma, colon carcinoma, and melanoma .
loading...
    loading...
Cat. No.: HY-U00088
CAS No.: 2697-85-0
Target:  

Others

Research Areas:  

Inflammation/Immunology Cancer

3b,7a,17a-Trihydroxyandrost-5-ene is a immune modulator extracted from patent US20030060425.
loading...
    loading...
Cat. No.: HY-10863S1
CAS No.: 2260669-86-9
Synonyms: AEA-d11
Anandamide-d11 is deuterium labeled Anandamide. Anandamide is an immune modulator in the central nervous system acts via not only cannabinoid receptors (CB1 and CB2) but also other targets (e.g., GPR18/GPR55) .
loading...
    loading...
Cat. No.: HY-17589BR
CAS No.: 3545-67-3
Chloroquine (dihydrochloride) (Standard) is the analytical standard of Chloroquine (dihydrochloride). This product is intended for research and analytical applications. Chloroquine dihydrochloride is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis. Chloroquine dihydrochloride is an autophagy and toll-like receptors (TLRs) inhibitor. Chloroquine dihydrochloride is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro (EC50=1.13 μM)[1][2][3][4].
loading...
    loading...